Sage Rhino Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.74M | Buy |
6,868
+242
| +4% | +$56.4K | 0.28% | 71 |
|
|
2026
Q1 | $1.62M | Sell |
6,626
-215
| -3% | -$50.1K | 0.3% | 67 |
|
|
2025
Q4 | $1.42M | Sell |
6,841
-69
| -1% | -$13.6K | 0.27% | 76 |
|
|
2025
Q3 | $1.28M | Buy |
6,910
+32
| +0.5% | +$5.48K | 0.25% | 79 |
|
|
2025
Q2 | $1.05M | Buy |
6,878
+143
| +2% | +$22K | 0.22% | 87 |
|
|
2025
Q1 | $1.12M | Sell |
6,735
-37
| -0.5% | -$5.79K | 0.26% | 76 |
|
|
2024
Q4 | $979K | Sell |
6,772
-109
| -2% | -$16.9K | 0.21% | 89 |
|
|
2024
Q3 | $1.12M | Sell |
6,881
-107
| -2% | -$17K | 0.25% | 81 |
|
|
2024
Q2 | $1.02M | Sell |
6,988
-47
| -0.7% | -$6.99K | 0.24% | 83 |
|
|
2024
Q1 | $1.11M | Buy |
7,035
+95
| +1% | +$15.1K | 0.26% | 77 |
|
|
2023
Q4 | $1.09M | Sell |
6,940
-23
| -0.3% | -$3.53K | 0.28% | 72 |
|
|
2023
Q3 | $1.08M | Sell |
6,963
-27
| -0.4% | -$4.46K | 0.3% | 69 |
|
|
2023
Q2 | $1.16M | Buy |
6,990
+13
| +0.2% | +$2.1K | 0.32% | 68 |
|
|
2023
Q1 | $1.08M | Sell |
6,977
-219
| -3% | -$35.4K | 0.32% | 66 |
|
|
2022
Q4 | $1.27M | Buy |
7,196
+46
| +0.6% | +$7.94K | 0.4% | 52 |
|
|
2022
Q3 | $1.17M | Sell |
7,150
-85
| -1% | -$14.4K | 0.47% | 40 |
|
|
2022
Q2 | $1.28M | Buy |
7,235
+36
| +0.5% | +$6.41K | 0.49% | 40 |
|
|
2022
Q1 | $1.28M | Buy |
7,199
+16
| +0.2% | +$2.72K | 0.39% | 45 |
|
|
2021
Q4 | $1.23M | Buy |
7,183
+155
| +2% | +$25.4K | 0.34% | 49 |
|
|
2021
Q3 | $1.14M | Buy |
7,028
+16
| +0.2% | +$2.73K | 0.35% | 52 |
|
|
2021
Q2 | $1.16M | Buy |
7,012
+101
| +1% | +$16.7K | 0.34% | 50 |
|
|
2021
Q1 | $1.14M | Buy |
6,911
+216
| +3% | +$35K | 0.37% | 46 |
|
|
2020
Q4 | $1.05M | Buy |
6,695
+72
| +1% | +$10.6K | 0.42% | 45 |
|
|
2020
Q3 | $986K | Buy |
6,623
+4
| +0.1% | +$592 | 0.48% | 41 |
|
|
2020
Q2 | $931K | Buy |
6,619
+139
| +2% | +$20.3K | 0.49% | 43 |
|
|
2020
Q1 | $850K | Buy |
6,480
+121
| +2% | +$17.2K | 0.61% | 35 |
|
|
2019
Q4 | $922K | Buy |
6,359
+53
| +0.8% | +$7.19K | 0.52% | 41 |
|
|
2019
Q3 | $816K | Buy |
6,306
+4
| +0.1% | +$527 | 0.51% | 44 |
|
|
2019
Q2 | $878K | Buy |
6,302
+74
| +1% | +$10.2K | 0.56% | 42 |
|
|
2019
Q1 | $871K | Buy |
+6,228
| New | +$834K | 0.58% | 39 |
|
Other funds holding JNJ
Sage Rhino Capital's JNJ Position: Q2 2026 in Review
Sage Rhino Capital increased its Johnson & Johnson (JNJ) stake by 3.7% in Q2 2026, buying an estimated $56.4K and bringing the position to 6,868 shares worth $1.74M. The position accounts for 0.28% of the portfolio, ranked #71.
Sage Rhino Capital first reported a position in JNJ in Q1 2019 and has held it in 30 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Sage Rhino Capital held 6,868 shares of Johnson & Johnson worth $1.74M as of Q2 2026.
- Sage Rhino Capital bought 242 Johnson & Johnson shares in Q2 2026, an estimated $56.4K.
- Johnson & Johnson made up 0.28% of Sage Rhino Capital's portfolio in Q2 2026, its #71 holding.
- Sage Rhino Capital first reported a position in Johnson & Johnson in Q1 2019 and has held it in 30 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.